Rouzier Cécile, Chaussenot Annabelle, Serre Valérie, Fragaki Konstantina, Bannwarth Sylvie, Ait-El-Mkadem Samira, Attarian Shahram, Kaphan Elsa, Cano Aline, Delmont Emilien, Sacconi Sabrina, Mousson de Camaret Bénédicte, Rio Marlène, Lebre Anne-Sophie, Jardel Claude, Deschamps Romain, Richelme Christian, Pouget Jean, Chabrol Brigitte, Paquis-Flucklinger Véronique
1] Department of Medical Genetics, National Centre for Mitochondrial diseases, Nice Teaching Hospital, Nice, France [2] IRCAN, CNRS UMR 7284/INSERM U1081/UNS, School of Medicine, Nice Sophia-Antipolis University, Nice, France.
Department of Medical Genetics, National Centre for Mitochondrial diseases, Nice Teaching Hospital, Nice, France.
Eur J Hum Genet. 2014 Apr;22(4):542-50. doi: 10.1038/ejhg.2013.171. Epub 2013 Aug 7.
Polymerase gamma (POLG) is the gene most commonly involved in mitochondrial disorders with mitochondrial DNA instability and causes a wide range of diseases with recessive or dominant transmission. More than 170 mutations have been reported. Most of them are missense mutations, although nonsense mutations, splice-site mutations, small deletions and insertions have also been identified. However, to date, only one large-scale rearrangement has been described in a child with Alpers syndrome. Below, we report a large cohort of 160 patients with clinical, molecular and/or biochemical presentation suggestive of POLG deficiency. Using sequencing, we identified POLG variants in 22 patients (18 kindreds) including five novel pathogenic mutations. Two patients with novel mutations had unusual clinical presentation: the first exhibited an isolated ataxic neuropathy and the second was a child who presented with endocrine signs. We completed the sequencing step by quantitative multiplex PCR of short fluorescent fragments (QMPSF) analysis in 37 patients with either only one POLG heterozygous variant or a family history suggesting a dominant transmission. We identified a large intragenic deletion encompassing part of intron 21 and exon 22 of POLG in a child with refractory epilepsia partialis continua. In conclusion, we describe the first large French cohort of patients with POLG mutations, expanding the wide clinical and molecular spectrum observed in POLG disease. We confirm that large deletions in the POLG gene are rare events and we highlight the importance of QMPSF in patients with a single heterozygous POLG mutation, particularly in severe infantile phenotypes.
聚合酶γ(POLG)是最常与线粒体DNA不稳定相关的线粒体疾病有关的基因,可导致多种隐性或显性遗传疾病。已报道了170多种突变。其中大多数是错义突变,不过也发现了无义突变、剪接位点突变、小缺失和插入突变。然而,迄今为止,仅在一名患有阿尔珀斯综合征的儿童中描述了一种大规模重排。下面,我们报告了一组160例临床、分子和/或生化表现提示POLG缺乏的患者。通过测序,我们在22例患者(18个家系)中鉴定出POLG变异,包括5种新的致病突变。两名携带新突变的患者有不寻常的临床表现:第一名表现为孤立性共济失调性神经病,第二名是一名出现内分泌症状的儿童。我们通过短荧光片段定量多重PCR(QMPSF)分析对37例仅携带一个POLG杂合变异或有显性遗传家族史的患者完成了测序步骤。我们在一名患有难治性部分性持续性癫痫的儿童中鉴定出一个大的基因内缺失,该缺失涵盖了POLG内含子21和外显子22的一部分。总之,我们描述了首个法国大型POLG突变患者队列,扩展了POLG疾病中观察到的广泛临床和分子谱。我们证实POLG基因中的大缺失是罕见事件,并强调了QMPSF在携带单个POLG杂合突变患者中的重要性,特别是在严重婴儿型表型中。